SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001558370-20-003966
Filing Date
2020-04-16
Accepted
2020-04-16 17:18:35
Documents
6

Document Format Files

Seq Description Document Type Size
1 S-3 tmb-20200416xs3.htm S-3 767216
2 EX-5.1 tmb-20200416xex5d1.htm EX-5.1 11961
3 EX-23.1 tmb-20200416xex23d1.htm EX-23.1 4672
4 EX-23.2 tmb-20200416xex23d2.htm EX-23.2 4258
5 GRAPHIC tmb-20200416xs3g001.jpg GRAPHIC 3116
6 GRAPHIC tmb-20200416xs3g002.jpg GRAPHIC 12704
  Complete submission text file 0001558370-20-003966.txt   811295
Mailing Address 373 INVERNESS PARKWAY SUITE 200 ENGLEWOOD CO 80112
Business Address 373 INVERNESS PARKWAY SUITE 200 ENGLEWOOD CO 80112 720-437-6500
Ampio Pharmaceuticals, Inc. (Filer) CIK: 0001411906 (see all company filings)

IRS No.: 260179592 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-237723 | Film No.: 20797135
SIC: 2834 Pharmaceutical Preparations